Tulane COVID Antibody Testing (or Long COVID/CSI studies)

Here you will find results from spike antibody testing for subjects participating in the Tulane IRB (2020-585) approved study: Seroepidemiology and Immunity of COVID-19 in Southern Louisiana. This includes the Tulane University Long COVID Study.

Instructions: Look up your testing results for presence of spike antibodies by your unique study ID. If you are unclear which study ID is yours or have other question, please contact the study team at SeroEpiCovid@tulane.edu or cobaltcovid@wave.tulane.edu. The date of visit is also included for your unique study ID

 Information about the spike antibody test: 

  1. The test we are using is not a perfect test, it is not FDA approved, and is a test being used for research purposes only. 
  2. This is NOT a test which should be used for a medical diagnosis. 
  3. There may be false positives (where you test positive, but you have not actually been exposed) and false negatives (where you test negative, but you actually have been exposed). 
  4. At this time, we do not know if having antibody protects you from being infected again and/or becoming sick with the virus. 
  5. You should not use the results from this research study to inform your medical treatment. 
  6. Results will be posted for the last 4 months of testing only.

Thank you for your participation in this study! 

Antibody Testing Results:

Results Code Spike antibodies Visit date
1495 Positive 9/30/21
1811 Positive 9/30/21
1659 Positive 10/5/21
1834 Positive 10/5/21
9316 Positive 10/5/21
9191 Positive 10/6/21
1367 Positive 10/7/21
2589 Positive 10/7/21
4897 Positive 10/7/21
9888 Positive 10/7/21
1266 Positive 10/9/21
4948 Positive 10/9/21
5153 Positive 10/9/21
8268 Positive 10/9/21
8808 Positive 10/9/21
9246 Positive 10/9/21
9432 Positive 10/9/21
3469 Positive 10/9/21
5738 Positive 10/12/21
7821 Positive 10/12/21
2162 Positive 10/14/21
3666 Positive 10/14/21
8578 Positive 10/14/21
9584 Positive 10/14/21
2473 Positive 10/19/21
8618 Positive 10/19/21
3424 Positive 10/20/21
7220 Positive 10/20/21
7338 Positive 10/20/21
5034 Positive 10/21/21
3892 Positive 10/26/21
4171 Positive 10/26/21
7145 Positive 10/26/21
7002 Positive 11/2/21
8701 Positive 11/2/21
2723 Positive 11/3/21
5062 Positive 11/3/21
5490 Positive 11/3/21
3141 Positive 11/9/21
4902 Positive 11/9/21
8563 Positive 11/9/21
1413 Positive 11/10/21
2422 Positive 11/10/21
3814 Positive 11/10/21
4447 Positive 11/10/21
6646 Positive 11/10/21
8391 Positive 11/10/21
9961 Positive 11/16/21
1066 Positive 11/17/21
5304 Positive 11/17/21
8597 Positive 11/20/21
3050 Positive 11/22/21
5742 Positive 11/22/21
4643 Positive 11/23/21
9569 Positive 11/23/21
3015 Positive 12/2/21
9689 Positive 12/7/21
2121 Positive 12/8/21
4915 Positive 12/9/21
5021 Positive 12/9/21
5419 Positive 12/9/21
7890 Positive 12/9/21
1433 Positive 12/14/21
4361 Positive 12/14/21
2439 Positive 12/15/21
3090 Positive 12/15/21
6940 Positive 12/15/21
6960 Positive 12/15/21
7718 Positive 12/15/21
9365 Positive 12/15/21
9568 Positive 12/15/21
3434 Positive 1/5/22
3871 Positive 1/5/22
8993 Positive 1/6/22
3079 Positive 1/11/22
5168 Positive 1/12/22
5651 Positive 1/12/22
3235 Positive 1/19/22
3472 Positive 1/19/22
3567 Positive 1/19/22
4409 Positive 1/19/22
6962 Positive 1/19/22
8598 Positive 1/19/22
8987 Positive 1/19/22
9016 Positive 1/19/22
4311 Positive 1/25/22
3100 Positive 1/26/22
4017 Positive 1/26/22
4740 Positive 1/27/22
6268 Positive 2/1/22
7111 Positive 2/1/22
9021 Positive 2/1/22
13469 Positive 2/2/22
1070 Positive 2/3/22
7062 Positive 2/3/22
7540 Positive 2/3/22
6022 Positive 2/9/22
6681 Positive 2/9/22
7695 Positive 2/9/22
8072 Positive 2/9/22
1248 Positive 2/15/22
7225 Positive 2/15/22
2703 Positive 2/16/22
3241 Positive 2/16/22
8019 Positive 2/16/22
9650 Positive 2/16/22
1000 Positive 2/22/22
3812 Positive 2/23/22
6064 Positive 2/23/22
9254 Positive 2/23/22
7709 Positive 3/8/22
8429 Positive 3/8/22
8534 Positive 3/8/22
9750 Positive 3/8/22
1258 Positive 3/12/22
4848 Positive 3/12/22
6418 Positive 3/12/22
6759 Positive 3/12/22
7033 Positive 3/12/22
7293 Positive 3/16/22
7647 Positive 3/16/22
6160 Positive 3/17/22
9179 Positive 3/17/22
9670 Positive 3/22/22
6336 Positive 3/23/22
8054 Positive 3/23/22
5705 Positive 3/24/22
6006 Negative 3/24/22
4230 Positive 3/29/22
4965 Positive 3/29/22
7011 Positive 3/29/22
1389 Positive 3/30/22
5193 Positive 3/30/22
4395 Positive 4/7/22
5128 Positive 4/12/22
5150 Positive 4/12/22
8332 Positive 4/12/22
5494 Positive 4/20/22
4263 Positive 4/26/22
1972 Positive 4/26/22
1383 Positive 5/3/22
5255 Positive 5/17/22
5977 Positive 5/18/22
6000 Positive 5/18/22
7864 Positive 5/18/22
1872 Positive 5/24/22
2685 Positive 5/24/22
3794 Positive 5/24/22
4137 Positive 5/24/22
1241 Positive 5/25/22
1302 Positive 5/25/22
17033 Positive 5/25/22
1407 Positive 5/26/22
1528 Positive 5/26/22
5524 Positive 5/26/22
9540 Positive 5/26/22
6839 Positive 5/27/22
5257 Positive 5/31/22
5365 Positive 5/31/22
6906 Positive 5/31/22
7490 Positive 5/31/22
9082 Positive 5/31/22
2797 Positive 6/7/22
4435 Positive 6/7/22
5908 Positive 6/7/22
7020 Positive 6/7/22
2111 Positive 6/14/22
4170 Positive 6/14/22
9417 Positive 6/14/22
1219 Negative 6/15/22
2659 Positive 6/15/22
6615 Positive 6/15/22
8601 Positive 6/15/22
9513 Positive 6/15/22
1795 Positive 6/21/22
5598 Positive 6/22/22
4102 Positive 6/29/22
8241 Positive 6/29/22
2312 Positive 7/12/22
2780 Positive 7/12/22
9746 Positive 7/12/22

 

 

Publications or Manuscripts From Ongoing U54 Serpent Project COVID Studies:

  1. Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE, Bilton SJ, Linhuber JP, Norton EB, Dietrich ML, Yee JK, Lai W, Scott JW, Yin XM, Rappaport J, Robinson JE, Saba NS, Roy CJ, Zwezdaryk KJ, Zhao Z, Hu TY. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest. 2021 Feb 9;. doi: 10.1172/JCI146031. [Epub ahead of print] PubMed PMID: 33561010.
  2. Schieffelin JS, Norton EB, Kolls JK. What should define a SARS-CoV-2 “breakthrough” infection?. J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI151186. PubMed PMID: 33974565; PubMed Central PMCID: PMC8203469.
  3. Dietrich M.L., Norton E.B., Elliott D., Smira A.R., Rouelle J.A., Bond N.G., Aime-Marcelin K., Prystowsky A., Kemnitz R., Sarma A., Himmelfarb S.T., Sharma N., Stone A.E., Craver R., Lindrose A.R., Smitley L.A., Uddo R.B., Myers L., Drury S.S., Schieffelin J.S., Robinson J.E., Zwezdaryk K.J. SARS-CoV-2 Seroprevalence Rates of Children in Louisiana During the State Stay at Home Order. Journal of Clinical Virology Plus. 2021 Dec; 1:4. PMID: 35262027.
  4. Amelie E.Murrell, Ewono Eyoh, Jeffrey G. Shaffer, Monika L. Dietrich, Ivy V. Trinh, Thomas J. Yockachonis, Shuangyi Bai, Crystal Y. Zheng, Celia V. Mayne, Sofia E. Cabrera, Anyssa Aviles-Amaro, Addison E. Stone, Saraswatie Rambaran, Sruti Chandra, Debra H.Elliott, Ashley R. Smira, Sara N. Harris, Katharine E. Olson, Samantha J. Bilton, Medea J.Gabriel, Nicole D. Falgout, Emily J. Engel, Alisha D. Prystowsky, Bo Ning, Tony Hu, Jay K.Kolls, Samuel J. Landry, Stacy S. Drury, John S. Schieffelin, Kevin J. Zwezdaryk, James E.Robinson, Bronwyn M. Gunn, Elizabeth B.  Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age. In submission, Preprint: medRxiv 2022.04.22.22274032; doi:https://doi.org/10.1101/2022.04.22.22274032
  5. Stephanie N. Seifert, Shuangyi Bai, Stephen Fawcett, Elizabeth B. Norton, Kevin J.Zwezdaryk, James Robinson, Bronwyn Gunn, Michael C. Letko. An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. In submission Preprint: bioRxiv 2021.12.05.471310; doi: https://doi.org/10.1101/2021.12.05.471310

Results Flyers:

To be updated soon….

Comments are closed.